- Home
- SERA vs SABA Comparison
SERA vs SABA Comparison
Compare SERA & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SERA | SABA |
|---|---|---|
| Founded | 2008 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 225.6M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SERA | SABA |
|---|---|---|
| Price | $1.73 | $8.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.8K | ★ 55.3K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.91% |
| EPS Growth | ★ 32.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,000.00 | N/A |
| Revenue This Year | $554.81 | N/A |
| Revenue Next Year | $517.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.19 | N/A |
| 52 Week Low | $1.37 | $7.96 |
| 52 Week High | $4.09 | $9.46 |
Technical Indicators
Market Signals| Indicator | SERA | SABA |
|---|---|---|
| Relative Strength Index (RSI) | 40.47 | 46.15 |
| Support Level | N/A | $8.24 |
| Resistance Level | $2.41 | $8.68 |
| Average True Range (ATR) | 0.21 | 0.12 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 28.81 | 14.90 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.